TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice - Concepedia

Concepedia

Publication | Open Access

TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice

DOI Full Paper Access

24

Citations

29

References

2015

Year

Erina Koga‐Yamakawa, Masashi Murata, Simon J. Dovedi, Robert W. Wilkinson, Yosuke Ota, Hiroki Umehara, Eiji Sugaru, Yuko Hirose, Hideyuki Harada, Philip J. Jewsbury,

Cancer Immunology Immunotherapy

Tlr7 ToleranceCancer ImmunosurveillanceAutoimmune DiseaseT-regulatory CellImmunologyTumor ImmunityIfn PathwaySelf-toleranceAutoimmunityAnti-tumor EfficacyTolerance InductionCellular Immune ResponseImmunotherapyMedicineRadiation OncologyTumor BiologyImmune Dysregulation

References

	Year	Citations

Page 1

Page 1